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Abstract
Background: Dengue is re-emerging throughout the tropical world, causing frequent recurrent epidemics. The initial clinical
manifestation of dengue often is confused with other febrile states confounding both clinical management and disease
surveillance. Evidence-based triage strategies that identify individuals likely to be in the early stages of dengue illness can
direct patient stratification for clinical investigations, management, and virological surveillance. Here we report the
identification of algorithms that differentiate dengue from other febrile illnesses in the primary care setting and predict
severe disease in adults.
Methods and Findings: A total of 1,200 patients presenting in the first 72 hours of acute febrile illness were recruited and
followed up for up to a 4-week period prospectively; 1,012 of these were recruited from Singapore and 188 from Vietnam.
Of these, 364 were dengue RT-PCR positive; 173 had dengue fever, 171 had dengue hemorrhagic fever, and 20 had dengue
shock syndrome as final diagnosis. Using a C4.5 decision tree classifier for analysis of all clinical, haematological, and
virological data, we obtained a diagnostic algorithm that differentiates dengue from non-dengue febrile illness with an
accuracy of 84.7%. The algorithm can be used differently in different disease prevalence to yield clinically useful positive and
negative predictive values. Furthermore, an algorithm using platelet count, crossover threshold value of a real-time RT-PCR
for dengue viral RNA, and presence of pre-existing anti-dengue IgG antibodies in sequential order identified cases with
sensitivity and specificity of 78.2% and 80.2%, respectively, that eventually developed thrombocytopenia of 50,000 platelet/
mm3 or less, a level previously shown to be associated with haemorrhage and shock in adults with dengue fever.
Conclusion: This study shows a proof-of-concept that decision algorithms using simple clinical and haematological
parameters can predict diagnosis and prognosis of dengue disease, a finding that could prove useful in disease
management and surveillance.
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Introduction
Dengue fever/dengue haemorrhagic fever (DF/DHF) is a re-
emerging disease throughout the tropical world. The disease is caused
by four closely related dengue viruses, which are transmitted by the
Aedesmosquitoes, principally Aedes aegypti [1]. DHF and dengue shock
syndrome (DSS) represent the severe end of the disease spectrum,
which if not properly managed, would result in significant mortality.
The pathophysiology of severe DHF and DSS is characterized by
plasma leakage as a result of alteration in microvascular permeability
[2]. There is as yet no vaccine or specific antiviral therapy for DF/
DHF and management of cases remains largely supportive [3].
Dengue illness is often confused with other viral febrile states,
confounding both clinical management [4–6] and disease
surveillance for viral transmission prevention [7]. This difficulty
is especially striking during the early phase of illness, where non-
specific clinical symptoms and signs accompany the febrile illness
[4]. More definitive symptoms, such as retro-orbital pain, and
clinical signs, such as petechiae, do not appear until the later stages
of illness, if at all. Definitive early dengue diagnosis thus requires
laboratory tests and those suitable for use at this stage of illness are
either costly, such as RT-PCR for dengue; not sufficiently rapid,
such as virus isolation; or undergoing field trials, such as ELISA for
NS1 protein of dengue virus [8,9]. Furthermore, many dengue
endemic places lack the necessary laboratory infrastructure or
support [7] and thus a scheme for reliable clinical diagnosis, using
data that can be obtained routinely, would be useful for early
recognition of dengue fever, not only for case management but
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also for dengue surveillance. The current World Health Organi-
zation (WHO) scheme for classifying dengue infection (Table S1)
makes use of symptoms and signs that are often not present in the
first few days of illness, and thus not a guide for early diagnosis, but
are instead designed for monitoring disease progression for clinical
management of the severe DHF/DSS. Other attempts at
identifying clinical features for the diagnosis of dengue disease
have made use of univariate or multivariate analysis of clinical
symptoms and signs, haematological or biochemical parameters
[10,11]. Although such studies provide a list of symptoms and signs
that could be associated with dengue disease, how these should be
applied for clinical diagnosis is not apparent. Evidence-based
triage strategies that identify individuals likely to have dengue
infection in the early stages of illness are needed to direct patient
stratification in clinical investigations, management and healthcare
resource planning.
To address this goal, we show here that a decision tree approach
can be useful to develop an intuitive diagnostic algorithm, using
clinical and haematological parameters, that is able to distinguish
dengue from non-dengue disease in the first 72 hours of illness. We
also demonstrate a proof-of-concept that such an approach can be
useful for early dengue disease prognostication.
Materials and Methods
Patients and clinical methods
Ethical considerations. The study protocol was approved
by each organization’s institutional review board. Patient
enrolment, clinical and epidemiological data collection within
the National Healthcare Group, Singapore was approved by the
NHG IRB (DSRB B/05/013). Patient enrolment, clinical and
epidemiological data collection in Dong Thap Hospital was
approved by the hospital scientific and ethical committee as well as
the Oxfordshire Tropical Research Ethical Committee, UK.
Enrolment of study participants was conditional on appropriate
informed consent administered by a study research nurse. All
biological materials collected were anonymized after completion of
demographic and clinical data collection.
Screening and recruitment. The protocol for patient
recruitment in Singapore (the early dengue infection and
outcome (EDEN) study) was described previously [12]. Adult
patients (age .18 years) presenting at selected primary care
polyclinics within 72 hours of onset of acute febrile illness and
without rhinitis or clinically obvious alternative diagnoses for fever
were eligible for study inclusion. Upon consent, anonymized
demographic, clinical and epidemiological information were
collected on a standardized data entry form on 3 occasions: 1–
3 days post-onset of fever (1st visit), 4–7 days post-onset of fever
(2nd visit) and 3–4 weeks post-onset of fever (3rd visit). Venous
blood was also collected for haematological, virological and
serological analyses at every visit. Remaining serum and blood
were anonymized and stored at 280uC until use. The list of
parameters monitored in this study is shown in the supplementary
Table S2.
Children or adults in whom there was a clinical suspicion of
dengue were recruited within 72 hours of illness onset in Dong
Thap Hospital, Vietnam. Blood samples were collected for
diagnostic investigations at study enrolment and again at hospital
discharge. Clinical data were collected daily on standard case
record forms.
Laboratory Methods
Haematology. A full blood count was performed on
anticoagulated whole blood collected at all time points. A
bench-top, FDA-approved haematocytometer was used for this
application (iPoch-100, Sysmex, Japan). Calibration by internal
and external QC controls was also performed on a regular basis.
Serology and antigen detection. IgM and IgG antibodies
against dengue virus were detected using commercially available
ELISAs (PanBio, Brisbane, Australia) according to manufacturer’s
instructions.
Reverse-transcription polymerase chain reaction (RT-
PCR). RNAs were extracted from the first serum portion or
virus culture supernatant using QIAamp Viral RNA mini kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. RT-PCR to detect dengue viral RNA was carried out
using a set of generic pan-dengue primers that targeted the 39 non-
coding region of dengue viruses as previously described [13].
Results were analysed with LightCycler software version 3.5
(Roche Diagnostics, Mannheim, Germany). Reactions with high
crossover threshold (Ct) value or ambiguous melting curve results
were analysed by electrophoresis on a 2% agarose gel, to confirm
presence of product of the correct size. RNA extracted from
previously obtained clinical isolates, namely dengue-1 (S144),
dengue-2 (ST), dengue-3 (SGH) and dengue-4 (S006), propagated
in C6/36 cell cultures were included as external control in every
RT-PCR run.
Decision tree analyses for disease modelling
Classifier modelling. The C4.5 decision tree classifier [14]
software Inforsense (InforSense Ltd., London, UK) was used. A
standard pruning confidence of 25% was used to remove branches
where the algorithm was 25% or more confident so as to avoid
having specific branches that would not be representative for
generalisation. This prevents over-fitting of the data.
The parameter ‘minimal cases’ represents a stopping criterion
for further partition of the data at specific decision nodes. Tree
growing at a specific decision node was stopped when at least one
class had equal or less cases than the ‘minimal cases’. This prevents
the tree from sub-dividing into overly specific nodes which have
little supporting data. Choosing an appropriate value for ‘missing
cases’ was done using k-fold cross validation (see below). Briefly,
various decision trees with different ‘minimal cases’ were
Author Summary
Dengue illness appears similar to other febrile illness,
particularly in the early stages of disease. Consequently,
diagnosis is often delayed or confused with other illnesses,
reducing the effectiveness of using clinical diagnosis for
patient care and disease surveillance. To address this
shortcoming, we have studied 1,200 patients who
presented within 72 hours from onset of fever; 30.3% of
these had dengue infection, while the remaining 69.7%
had other causes of fever. Using body temperature and the
results of simple laboratory tests on blood samples of
these patients, we have constructed a decision algorithm
that is able to distinguish patients with dengue illness
from those with other causes of fever with an accuracy of
84.7%. Another decision algorithm is able to predict which
of the dengue patients would go on to develop severe
disease, as indicated by an eventual drop in the platelet
count to 50,000/mm3 blood or below. Our study shows a
proof-of-concept that simple decision algorithms can
predict dengue diagnosis and the likelihood of developing
severe disease, a finding that could prove useful in the
management of dengue patients and to public health
efforts in preventing virus transmission.
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calculated and the value resulting in the tree with the best
performance was chosen.
The calculated algorithms were validated using the k-fold cross-
validation approach. This is considered to be a powerful
methodology to overcome data over-fitting [15]. Briefly, the
original sample was divided into k sub-samples. Each sub-sample
was put aside as evaluation data for testing a model, and the
remaining k-1 sub-samples were used for training the model. The
cross-validation process was repeated k times (folds) and each of
the k sub-samples was used once as the validation data. The k
results obtained from the k-folds could then be averaged to
produce a single estimation of model performance [15]. The fold
value was set to k = 10.
To analyse the sensitivity and specificity of the decision
algorithm, an averaged receiver-operating characteristic (ROC)
curve was constructed. The area under the curve (AUC) serves as
an indicator of the overall performance of the algorithm. The
algorithms with the highest sensitivity along with a high AUC were
selected.
Statistical analysis
All results have been summarized in terms of means and
standard deviation for continuous variables using independent
sample T-test. Shapiro-Wilk normality test was used to check for
non-normally distributed parameters whereby a p value ,0.05
indicated that the parameter was unlikely to originate from a
normal distribution. Non-normally distributed parameters were
log-transformed and rechecked for normality. If the log-transfor-
mation still resulted in non-normal distribution, non-parametric
Kruskal-Willis test was used for continuous variables whereas
Student’s t test was exploited for normally distributed continuous
variables. For dichotomous variables, Chi-square test was used in
case of expected frequencies that were higher than 5, whereas
Fisher’s exact test was performed when the expected table values
were smaller than 5. Cases with missing values were excluded from
the analysis and thus, the number of cases used for calculations
varied between different covariates. All calculations were per-
formed using Systat for Windows (SYSTAT Software Inc. San
Jose, CA). A two-tailed p value ,0.05 was considered as
statistically significant.
Results
We constructed a decision tree for dengue diagnosis with 1,200
patients with acute febrile illness. Of these, 1,012 were recruited
from the EDEN study and 188 from Vietnam. The EDEN cohort
consisted of 173 DF, 3 DHF and 836 non-dengue cases while the
Vietnam cohort consisted of 168 DHF and 20 DSS cases, resulting
in a total of 364 dengue and 836 non-dengue cases used for our
diagnostic tree construction.
The resulting diagnostic algorithm is shown in Figure 1. The
first splitting parameter is a platelet count of 196,000/mm3 blood
or less followed by the total white cell or lymphocyte counts, body
temperature, haematocrit or neutrophil count and another platelet
count at presentation. The predicted diagnosis is shown in colours,
with red indicating probable dengue, brown indicating likely
dengue, green indicating likely non-dengue and blue indicating
probable non-dengue (Figure 1A). Each of the nodes showed
statistical significance in the proportion of dengue and non-dengue
cases, with the odds ratio calculated as shown in Figure 1B. The
performance of this algorithm is shown in Figure 2. The overall
error rate estimated after k-fold cross validation was 15.7%, with a
sensitivity and specificity of 71.2% and 90.1%, respectively
(Figure 2B).
Prediction of disease severity
We also examined if the use of a decision tree would be useful
for prognostication.
For the EDEN cohort, we used a platelet count of less than
50,000/mm3 on days 5 to 7 of illness as a marker of severe disease.
This level of thrombocytopenia has been shown to be associated
with the development of complications such as bleeding and shock
in adults [16–18].
Fifteen cases were excluded from this analysis as they were either
admitted to private hospitals where access to the clinical information
was not available to us, or were foreigners who returned to their
country of origin to seek medical treatment. Thus, 161 Singaporean
dengue cases were analysed and the pruning confidence was set to
25% with minimal cases defined as 16.
The best performing decision algorithm made used of platelet
count, the crossover value (Ct) of the real-time RT-PCR for
dengue viral RNA (a marker for viremia levels) and the presence of
anti-dengue IgG antibodies, as the first, second and third splitting
parameters, respectively (Figure 3). All 3 parameters were obtained
from the first visit. All three DHF cases were correctly classified
using this algorithm, one into the group with a platelet count of
108,000 mm3 or less, the other two into the group with pre-
existing anti-dengue IgG antibodies. The predicted outcome of
disease is shown in colours, with red indicating probable severe
dengue, brown indicating likely severe dengue, green indicating
likely non-severe dengue and blue indicating probable non-severe
dengue (Figure 3A). The statistical significance of each node of the
algorithm and their odds ratio with severe dengue are shown in
Figure 3B. The performance of this algorithm is shown in Figure 4.
The overall error rate using k-fold crossover validation analysis
was 20.5%, with a sensitivity of 78.2% and specificity of 80.2%
(Figure 4B).
The use of data obtained from the 89 hospitalised cases alone
resulted in a very similar decision algorithm, although the AUCs
were substantially lower than the above analysis due largely to the
smaller dataset. Taken together, these indicate that the prediction
algorithm as defined in Figure 3A is stable.
We next examined the clinical outcomes of the patients grouped
according to the decision algorithm in Figure 3A. The results are
summarised in Table 1. Each of the four groups of patients showed
different rates of hospitalisation, duration of hospitalisation and
the proportion of clinically severe cases. The latter was defined as
patients who met the criteria for DHF; had a systolic blood
pressure less than 90 mmHg; a serum transaminase of greater
than 1000 which suggests severe liver involvement and who
received blood transfusion. The results indicate that statistically
significant differences were observed between the groupings as
indicated in Table 1.
Discussion
The lack of evidence-based diagnostic algorithm for early
dengue diagnosis as well as prognostic triage strategies limits
effective patient management, use of healthcare resources and
disease surveillance efforts. For instance, over 80% of the total
dengue cases in Singapore are admitted for hospitalised care,
mostly to monitor for signs of clinical deterioration. Prognostica-
tion in the early stages of dengue illness could significantly
influence clinical management and the use of healthcare resources,
particularly during dengue outbreaks, such as occurred in
Singapore in 2005 where up to 8% of all acute hospitals beds
available were occupied by dengue cases [19].
To identify the decision algorithms, we have used a C4.5
decision tree classifier, which has several advantages over other
Decision Algorithms for Dengue
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statistical tools [14]. Briefly, decision algorithms are in principle
simple to understand and are able to handle both nominal and
categorical data. Importantly, they are also able to handle missing
values, which are commonly encountered in clinical studies. In
contrast, logistic regression and discriminant analyses require
much more data preparation and appropriate handling of missing
values for reliable calculations [15]. Decision algorithms are also
easy to interpret, use and validate using common statistical
techniques. Importantly, it provides a means to identify param-
eters that would be significantly associated with disease when
analysed in sub-groups but not in the total study population. To
our understanding, this is the first time decision tree modelling has
been used to identify prognostic markers for dengue disease.
While dengue is predominantly a paediatric disease, dengue in
adults has become an increasingly recognised problem, both in
dengue-endemic regions [6,20] as well as in adult travellers
Figure 1. Decision algorithm for dengue diagnosis. A. Decision algorithm for predicting dengue diagnosis calculated on 1200 patients with
data obtained in the first 72 hours of illness. PLT = platelet count; WBC=white blood cell count; T = body temperature; HCT= hematocrit;
Lymphocyte= absolute number of lymphocytes; Neutrophil = absolute number of neutrophils. The prediction of the algorithm is shown in colours: Red
indicates probable dengue; brown indicate likely dengue; green indicates likely non-dengue and blue indicates probably non-dengue. B. Statistical
(chi-square) analysis of splitting criteria performed on each subgroup at the decision nodes. OR= odds ratio; CI = 95% confidence interval.
doi:10.1371/journal.pntd.0000196.g001
Decision Algorithms for Dengue
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returning from the tropics [5]. The case recruitment in Singapore
has thus focused on adult cases. Since the course of disease in all
but three of the Singaporean adult cases were consistent with DF
instead of DHF, we have included 188 DHF/DSS paediatric and
adult cases from Vietnam in order to ensure that the diagnostic
algorithm developed here is robust across a spectrum of dengue
presentations.
The decision algorithm for the diagnosis of dengue within the
first three days of illness made use of a combination of platelet
count, total white cell count, body temperature, absolute
lymphocyte and neutrophil counts, in sequential order
(Figure 1A). Each node of the decision tree has statistically
significant odds ratio ranging from 5.9 to 13.8 (Figure 1B).
Although the tree has an optimal combined sensitivity and
specificity of 71.2% and 90.3%, respectively, its usage can be
adjusted according to the objective in which it is used for. In an
outbreak where the aim is to identify all dengue cases for
laboratory investigation and clinical follow-up, the tree could be
used to exclude dengue cases whereupon all cases except those
predicted as probable non-dengue (shown in blue in Figure 1A) are
tested for dengue virus. When applied hypothetically to an
outbreak similar to that observed in Singapore in 2005 where 29%
of the acute febrile cases recruited into our study was dengue, the
positive and negative predictive values of the tree are 57.7% and
94.4%, respectively. Conversely, when the dengue prevalence is
low as was encountered in our EDEN study between 2006 and
August 2007 where only 43 out of 555 (7.7%) cases presenting with
acute febrile illness were dengue, increasing the specificity of
clinical diagnosis by selecting patients with probable dengue
(shown in red in Figure 1A) would result in a positive and negative
Figure 2. Performance of the decision algorithm for dengue diagnosis. A. Receiver operating characteristics (ROC) curve for the diagnostic
algorithm in predicting dengue positive and dengue negative cases. B. Summary of K-fold (k = 10) cross-validation analysis for the dengue diagnostic
algorithm with 262 analysis for the algorithm’s sensitivity and specificity in dengue diagnosis.
doi:10.1371/journal.pntd.0000196.g002
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predictive values of 51.1% and 97.7%, respectively. Such a level of
positive predictive value would be useful to guide the selection of
patients for virological surveillance, a critical part of any dengue
prevention program [7,21–23].
Upon diagnosis, current dengue management strategies require
daily observation for signs of clinical deterioration, particularly for
clinical or laboratory evidence of hemorrhage or plasma leakage. In
situations of high prevalence of dengue illness, such an approach can
quickly overwhelm limited healthcare resources. It would be
advantageous to be able to stratify dengue cases for clinical follow-
up and management based on the likely outcome of disease. We thus
searched for an algorithm that could be used for prognostication.
Since the incidence of DHF is low in Singapore [20] and
hospitalisation of the dengue cases is subject to variation arising
from physician-to-physician differences in decision-making, we have
used platelet count nadir of 50,000/mm3 or less at 5 to 7 days after
onset of illness as an objective end-point for our analysis. This level of
thrombocytopenia has been found to be associated with increased
risks of haemorrhage and shock in adults with DF [16–18]. We were
unable to include the DHF and DSS cases recruited in Vietnam for
the tree construction as daily laboratory parameters comparable to
those collected for the Singapore cohort were not available.
The decision algorithm for prognostication (Figure 3A) uses the
platelet count as the first splitting criteria, followed by the dengue
Figure 3. Decision algorithm for predicting severe dengue disease. A. Decision algorithm for severity prediction calculated on 169 patients
with clinical data obtained at the first visit. PLT = platelet count; Ct = viral load whereby a high Ct-value indicates a low viral load; DV IgG= indicator for
primary/secondary infection whereby a positive result indicates a secondary infection. Low= platelet nadir of 50,000/mm3 or less; high= platelet nadir
greater than 50,000/mm3. The prediction of the algorithm is shown in colours: Red indicates probably severe dengue; brown indicates likely severe
dengue; green indicates likely non-severe dengue and blue indicates probable non-severe dengue B. Statistical (chi square) analysis of splitting
criteria performed on each subgroup at the decision nodes. OR= odds ratio; CI = 95% confidence interval.. PLT = platelet count; Ct = crossover threshold
value of real-time RT-PCR and indicative of level of viremia; DV IgG= indicator for primary/secondary infection whereby a positive result indicates a
secondary infection; OR= odds ratio; CI = confidence interval.
doi:10.1371/journal.pntd.0000196.g003
Decision Algorithms for Dengue
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Figure 4. Performance of the decision algorithm for predicting severe dengue disease. A. Receiver operating characteristics (ROC) curve
for the algorithm in predicting the development of severe disease among dengue cases. B. Summary of K-fold (k = 10) cross-validation for severity
prediction algorithm with 262 analysis for the algorithm’s sensitivity and specificity in predicting severe dengue disease.
doi:10.1371/journal.pntd.0000196.g004
Table 1. Number of cases hospitalised; mean number of days hospitalised and the number of clinically severe dengue cases from
the EDEN cohort, grouped according to the dengue case prognosis algorithm shown in Figure 3A.
Prognostic tree grouping
No. of cases
hospitalised (%)
Mean number of days
hospitalised SD (days) No. of clinically severe cases (%){
Probable severe dengue (n = 26) 25 (96.2) 5.2 1.4 10 (38.5)
Likely severe dengue (n = 38) 26 (63.4) 4.9 1.6 9 (23.7)
Likely non-severe dengue (n = 49) 27# (55.1) 3.9* 1.2 4 (8.2)#
Probable non-severe dengue (n = 48) 10** (20.8) 3.5** 1.2 0#
{indicates cases with DHF/SBP,90mmHg/serum transaminase.1000/transfusion.
*p,0.05 and ** p,0.001 when compared to either probable severe dengue or likely severe dengue. # indicates p,0.05 when compared to the probable severe
dengue only.
doi:10.1371/journal.pntd.0000196.t001
Decision Algorithms for Dengue
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virus genome copy number estimated by real-time RT-PCR as
the second splitting criteria for those with platelet count greater
than 108,000/mm3 blood. The second splitting criterion is a
marker of viral load. Although we have used the Ct value of our
real-time RT-PCR in this analysis, it is likely that other
parameters that provide estimates for the viral load could be
substituted for the viral genome copy numbers. The develop-
ment of NS1 antigen ELISA that is currently being evaluated in
several places could be one such alternative. The third splitting
criterion uses the presence of anti-dengue IgG antibody,
indicating secondary infection.
Although thrombocytopaenia [16–18], high viremia [24] and
presence of pre-existing anti-dengue antibodies [24–26] have
previously been reported to be associated with severe disease, how
these factors should be used clinically for prognostication has never
been described. Furthermore, using these parameters singly also
presents difficulties since these parameters are dynamic and the
window period in which these parameters offer peak predictive
values is extremely short [9]. The use of a decision tree approach
could thus provide clinicians with an algorithm to guide the
evaluation of a panel of critical laboratory parameters and the
sequential order these should be considered within the first
72 hours of illness.
Each of the four groups of patients under the decision algorithm
for prognosis (Figure 3A) also showed significant differences in
clinical outcome (Table 1). While only three cases met all the
criteria for DHF according to the WHO dengue classification, the
clinical records of another 20 cases showed that they either had a
period of hypotension (systolic blood pressure of less than
90mmHg) or severe liver inflammation (liver transaminas-
es.1000), both without documented pleural effusion, ascites or
rise in serial hematocrit, or received platelet/blood transfusion.
These clinical parameters have been previously observed in severe
dengue [15,16] and we have taken these cases collectively as
clinically severe outcomes. Of these 23 cases, 19 (82.6%) were
predicted by our tree as either probable severe dengue or likely
severe dengue with data obtained in the first three days of illness.
Conversely, 91.8% and 100% of the patients in the groups
predicted by our tree as either likely non-severe dengue or
probable non-severe dengue, respectively, did not show severe
clinical outcomes (Table 1).
The use of such a prognostic algorithm could prove useful in
segregating patients according to likely clinical outcomes to guide
clinical management and follow-up visits. Although our EDEN
cohort in Singapore has focused on dengue in the adult
population, our findings demonstrate a proof-of-concept that the
use of simple haematological and virological parameters is
predictive of disease outcome, and can be built upon to develop
prognosis-based protocols for dengue case management that
begins at the primary healthcare setting.
Our study represents the first to demonstrate that decision
algorithms for dengue diagnosis and prognosis can be developed
for clinical use. While a large multi-centre prospective study will be
needed for these algorithms to be applied globally, our analysis
indicates that a decision tree approach can differentiate dengue
from non-dengue febrile illness and predict outcome of disease.
Supporting Information
Table S1 Criteria for the classification of DF/DHF and the
recommended approach to diagnosis, according to the WHO
Guidelines.
Found at: doi:10.1371/journal.pntd.0000196.s001 (0.03 MB
DOC)
Table S2 Parameters and the respective units of measure used in
the EDEN study to monitor the recruited cases in all three visits.
Found at: doi:10.1371/journal.pntd.0000196.s002 (0.06 MB
DOC)
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